Concepedia

Publication | Closed Access

A multicenter, randomized, double-blind, PLB-controlled trial of Galectin-3 inhibitor (GR-MD-02) in patients with NASH cirrhosis and portal hypertension

DOI

16

Citations

0

References

2018

Year

Naga Chalasani, G. García-Tsao, Z. Goodman, E.J. Lawitz, Manal F. Abdelmalek, Mary E. Rinella, Mohamed Ryan, Mazen Noureddin, C. Jue, Mariia E. Pyko,
Journal of Hepatology

No additional data available for this publication yet. Check back later!